HIV/AIDS
Research from the United States and Italy provides new data about HIV/AIDS
Published in AIDS Weekly, March 5th, 2007
Study 1: A new study, "3'-Azido-3'-deoxythymidine-(5')-tetraphospho-(5')-adenosine, the product of ATP-mediated excision of chain-terminating AZTMP, is a potent chain-terminating substrate for HIV-1 reverse transcriptase," is now available. According to a study from the United States, "The resistance of HIV-1 to 3'-azido-3'-deoxythymidine (AZT) involves phosphorolytic excision of chain-terminating AZT-5'-monophosphate (AZTMP). Both pyrophosphate (PPi) and ATP act as excision substrates in vitro, but the intracellular substrate used during replication of AZT-resistant HIV is still...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2007-03-05)
More Articles from AIDS Weekly
- Financials
Polydex Pharmaceuticals Issues Interim Report on Business Operations - Gene Therapy
RNAi Shows Promise in Gene Therapy, Stanford Researcher Says - HIV/AIDS
Africa's first large-scale HIV vaccine study launches - HIV/AIDS
AIDS Healthcare Foundation to Petition FDA to Stop Pfizer Pursuit of OTC Approval for Viagra - HIV/AIDS
Amarillo Biosciences Announces Open Enrollment in its Phase 2 Study of Orally Administered Interferon Alpha in the Treatment of Oral Warts in HIV-Positive Patients - HIV/AIDS
Anti-HIV Medication PREZISTA (Darunavir) Receives Conditional Marketing Authorisation In The European Union - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
